BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kondo R, Furukawa N, Deguchi A, Kawata N, Suzuki Y, Imaizumi Y, Yamamura H. Downregulation of Ca2+-Activated Cl- Channel TMEM16A Mediated by Angiotensin II in Cirrhotic Portal Hypertensive Mice. Front Pharmacol 2022;13:831311. [PMID: 35370660 DOI: 10.3389/fphar.2022.831311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yuan L, Tang Y, Yin L, Lin X, Luo Z, Wang S, Li J, Liang P, Jiang B. The role of Transmembrane Protein 16A (TMEM16A) in pulmonary hypertension. Cardiovasc Pathol 2023;65:107525. [PMID: 36781068 DOI: 10.1016/j.carpath.2023.107525] [Reference Citation Analysis]
2 Jimenez C, Hawn MB, Akin E, Leblanc N. Translational potential of targeting Anoctamin-1-Encoded Calcium-Activated chloride channels in hypertension. Biochem Pharmacol 2022;206:115320. [PMID: 36279919 DOI: 10.1016/j.bcp.2022.115320] [Reference Citation Analysis]
3 Kawata N, Kondo R, Suzuki Y, Yamamura H. Increased TMEM16A-mediated Ca2+-activated Cl- currents in portal vein smooth muscle cells of caveolin 1-deficient mice. Biol Pharm Bull 2022. [PMID: 35989294 DOI: 10.1248/bpb.b22-00514] [Reference Citation Analysis]